… with PD and from healthy control volunteers. Participants visit their local study site twice for study visits. Data … samples for a project that the study’s scientific review committee is enthusiastic about. However — here’s where the challenge lies — BioFIND currently does not have …

… Study Rationale: Two proteins, PINK1 and Parkin, prevent cell death by breaking down damaged mitochondria, cell's energy generators. This process is known … affects the course of PD. Study Design: We will analyze the complete sets of genetic information and other data from …

… your submission. Home Page Cancel Register for Webinar New to Parkinson's? Steps to Take Today First Name   Last Name   … had PD I am a researcher, clinician or work with the PD community Other   Diagnosis Date ${selected} Jan Feb Mar Apr … must have Javascript and Cookies enabled in your browser preferences to access this webinar. Privacy Policy Terms & …

… your submission. Home Page Cancel Register for Webinar New to Parkinson's? Steps to Take Today First Name   Last Name   … had PD I am a researcher, clinician or work with the PD community Other   Diagnosis Date ${selected} Jan Feb Mar Apr … must have Javascript and Cookies enabled in your browser preferences to access this webinar. Privacy Policy Terms & …

… Objective/Rationale :  Glial cell-derived neurotrophic factor (GDNF) has been shown in various pre-clinical models of Parkinson's disease (PD) to restore … the brain. The approach integrates the use of four distinct components: a customized, implantable catheter system for …

… Study Rationale: While significant strides have been made toward therapies that can prevent, slow or stop Parkinson's … new treatment strategy is potentially more efficient when compared to other approaches, such as those that use antibodies. Cells can freely travel into the brain where alpha-synuclein clumps are located while antibodies -- …